Nice End to a Good Day of Trading on ENTB
Yes, it looked good and it closed nicely at 1.81, with nothing to indicate that there's any real trouble on the horizon. I'd like to see it hit 2 for a couple of reasons, not least of which is that capital investment loves a winner, thereby attracting even more capital investment.
2 would certainly be a milestone, no doubt. A hypothetical; what if ENTB can hit that mark? How hard would it be for the stock to improve from there? Personally, I think there's still room for positive improvement as word of its information suites and their capabilities gains wider notice. Maybe I can bribe one of those fellows from "Bulls and Bears" on Fox News Channel to take a look at it?
At any rate, with Borgin on board and heading up its biomed research capability I have a lot of confidence that the quality and success of its clinical trials protocols are going to attract more than enough attention from certain medical research firms. ENTB looks like it's got a strong hand to play these days now that it's got the biomed side of the house in order.
I don't know long it'll take to hit the 52-week high (6.50) again but if it can keep close, at the end of the day, to its daily high (it was 1.82 today, I think), after sell-offs and such, I think investor confidence improves.
Certainly, it's made a few strong moves in the stem cell extraction instrumentation field and I've had a chance to read its recent publication in the Journal of Translational Medicine ("Lasers, stem cells, and COPD"). It's very exciting.
Yes, it looked good and it closed nicely at 1.81, with nothing to indicate that there's any real trouble on the horizon. I'd like to see it hit 2 for a couple of reasons, not least of which is that capital investment loves a winner, thereby attracting even more capital investment.
2 would certainly be a milestone, no doubt. A hypothetical; what if ENTB can hit that mark? How hard would it be for the stock to improve from there? Personally, I think there's still room for positive improvement as word of its information suites and their capabilities gains wider notice. Maybe I can bribe one of those fellows from "Bulls and Bears" on Fox News Channel to take a look at it?
At any rate, with Borgin on board and heading up its biomed research capability I have a lot of confidence that the quality and success of its clinical trials protocols are going to attract more than enough attention from certain medical research firms. ENTB looks like it's got a strong hand to play these days now that it's got the biomed side of the house in order.
I don't know long it'll take to hit the 52-week high (6.50) again but if it can keep close, at the end of the day, to its daily high (it was 1.82 today, I think), after sell-offs and such, I think investor confidence improves.
Certainly, it's made a few strong moves in the stem cell extraction instrumentation field and I've had a chance to read its recent publication in the Journal of Translational Medicine ("Lasers, stem cells, and COPD"). It's very exciting.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
